Oncotarget

Research Papers:

IL-6-stimulated CD11b+ CD14+ HLA-DR myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus

Miao-Fen Chen _, Feng-Che Kuan, Tzu-Chen Yen, Ming-Shian Lu, Paul-Yang Lin, Yi-Hsiu Chung, Wen-Cheng Chen and Kuan-Der Lee

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2014; 5:8716-8728. https://doi.org/10.18632/oncotarget.2368

Metrics: PDF 1831 views  |   HTML 2474 views  |   ?  


Abstract

Miao-Fen Chen1,2, Feng-Che Kuan2,3, Tzu-Chen Yen4,5 , Ming-Shian Lu6, Paul-Yang Lin7, Yi-Hsiu Chung5, Wen-Cheng Chen1,2 and Kuan-Der Lee2,3

1 Department of Radiation Oncology, Chang Gung Memorial Hospital at Chiayi, Taiwan

2 Chang Gung University, College of Medicine, Taiwan

3 Hematology and Oncology, Chang Gung Memorial Hospital at Chiayi, Taiwan

4 Nuclear Medicine Department, Chang Gung Memorial Hospital at Linko, Taiwan

5 Center for Advanced Molecular Imaging and Translation, Chang Gung Memorial Hospital, at Linko, Taiwan

6 Thoracic & Cardiovascular Surgery, Chang Gung Memorial Hospital at Chiayi, Taiwan

7 Pathology, Chang Gung Memorial Hospital at Chiayi, Taiwan

Correspondence:

Miao-Fen Chen , email:

Keywords: IL-6; esophageal SCC; MDSC

Received: July 07, 2014 Accepted: August 18, 2014 Published: August 19, 2014

Abstract

The aim of this study was to assess the significance of myeloid-derived suppressor cells (MDSCs) and their association with IL-6 in esophageal squamous cell carcinoma (SCC). We examined the percentage of CD11b+CD14+HLA-DR myeloid cells and the levels of IL-6 in the peripheral blood of 50 patients with esophageal SCC and 12 healthy controls. Moreover, we evaluated the relationship between MDSC recruitment, IL-6 levels, and tumor progression by adding 4-nitroquinoline 1-oxide (4-NQO) to the drinking water of mice to induce esophageal tumors. Here we demonstrated that circulating CD11b+CD14+HLA-DR cells were significantly increased in esophageal SCC patients compared with healthy people, and this was associated with the clinical stage, treatment response and circulating IL-6 levels. In a 4-NQO-induced esophageal tumor animal model, MDSC recruitment was associated with invasive esophageal tumors and with increased IL-6 levels. IL-6 stimulated reactive oxygen species, arginase 1 and p-STAT3 in MDSCs. Blockade of IL-6 prevented induction of MDSCs and the incidence of 4-NQO- induced invasive tumors. In conclusion, the levels of MDSCs and IL-6 predicted the prognosis of patients with esophageal SCC. Moreover, we suggest inhibition of IL-6 as a potential strategy for the treatment of esophageal SCC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 2368